Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-07-26
1999-03-23
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241431, 5303873, 53038822, 435334, 435346, A61K 39395, C12P 2108, C07K 1628
Patent
active
058855742
ABSTRACT:
Antibodies and fragments thereof which activate an erythropoietin receptor and stimulate erythropoiesis are described. Also described are hybridoma cell lines which produce the antibodies and methods and compositions for the treatment of anemia.
REFERENCES:
patent: 4667016 (1987-05-01), Lai et al.
patent: 4703008 (1987-10-01), Lin
patent: 4816567 (1989-03-01), LaBilly et al.
patent: 5225539 (1993-07-01), Winter
patent: 5278065 (1994-01-01), D'Andrea et al.
patent: 5545806 (1996-08-01), Lonberg et al.
Ledbetter, J.A. et al. Advanced Drug Delivery Reviews 2: 319-342, 1988.
Fisher, M.J. et al. Blood 84: 1982-1991, Sep. 1994.
D'Andrea, A. et al. J. Cell Biochem. Suppl. 13 Part C: 25, Feb. 1989.
D'Andrea, A. et al. Blood 75:874-880, Feb. 1990.
Bailey et al. Exp. Hematol. 21, 1535-1543 (1993).
Baynes et al. Blood 82, 2088-2095 (1993).
Broudy et al. Proc. Nat. Acad. Sci. USA 85, 6517 (1988).
Chiba et al. Nature 362, 646 (1993).
Chiba et al. Proc. Natl. Acad. Sci. USA 90, 11593 (1993).
D'Andrea et al. Blood 82, 46-52 (1993).
D'Andrea et al. Cell 57, 277 (1989).
D'Andrea et al. in The Biology of Hemtaopoiesis, Wiley-Liss, Inc. (1990) pp. 153-159.
DeClerck et al. J. Biol. Chem. 266, 3893 (1991).
Dong & Goldwasser (Exp. Hematol. 21, 483 (1993).
Eschbach et al. (N. Engl J Med 316, 73 (1987).
Fiagerstam et al. J. Mol. Recognition 3, 208 (1990).
Fisher et al. Blood 82, 197A (1993).
Fuh et al. Science 256, 1677 (1992).
Harris et al. J. Biol. Chem. 267, 15205 (1992).
Hunt et al., Exp. Hematol., 19: 779 (1991).
Iscove et. al. J. Cell. Physiol 83, 309 (1974).
Jones et al. Blood 76, 31 (1990).
Komatsu et al. Blood 82, 456 (1993).
Koury Science 248, 378 (1990).
Laemmli et al. Nature 227, 680 (1970).
Liboi et al. Proc. Natl. Acad. Sci. USA 90, 11351 (1993).
Malmbory et al. Scand. J. Immunol. 35, 643 (1992).
Mayeux et al. Eur. J. Biochem. 194, 271 (1990).
Mayeux et al. J. Biol. Chem. 266, 23380 (1991).
McCaffery et al. J. Biol. Chem. 264, 10507 (1991).
Miura & Ihle Arch. Biochem. Biophys. 306, 200 (1993).
Miura & Ihle Blood 81, 1739 (1993).
Miyake et al. J. Biol. Chem. 252, 5558 (1977).
Noguchi et al. Mol. Cell. Biol. 8, 2604 (1988).
Patel et al. J. Biol. Chem. 267, 21300 (1992).
Pharr et al. Proc. Natl. Acad. Sci. USA 90, 938 (1993).
Sawyer J. Biol. Chem. 264, 13343 (1989).
Schreiber et al. Proc. Natl. Acad. Sci. USA 78, 7535 (1981).
Wigler et al. Cell 11, 223 (1997).
Winkelmann et al. Blood 76, 24 (1990).
Yet & Jones Blood 82, 1713 (1993).
Yoshimura et al. NAture 348, 647 (1990).
Amgen Inc.
Eisenschenk Frank C.
Levy Ron K.
Odre Steve M.
Rabin Evelyn
LandOfFree
Antibodies which activate an erythropoietin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies which activate an erythropoietin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies which activate an erythropoietin receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2122560